Eikon Therapeutics, Inc. Common Stock (EIKN) — Tangible Net Worth Ratio
Eikon Therapeutics, Inc. Common Stock (EIKN) has a Tangible Net Worth Ratio of 100.0% as of March 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($550.67 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. For live market cap and overall valuation, see Eikon Therapeutics, Inc. Common Stock stock valuation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Annual Tangible Net Worth Ratio for Eikon Therapeutics, Inc. Common Stock (None–None)
The table below presents the year-by-year Tangible Net Worth Ratio for Eikon Therapeutics, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See how financially flexible is Eikon Therapeutics, Inc. Common Stock to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|